Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Oral Oncol ; 78: 151-155, 2018 03.
Artículo en Inglés | MEDLINE | ID: mdl-29496043

RESUMEN

OBJECTIVE: The addition of induction chemotherapy (ICT) to concurrent chemoradiation (CCRT) has been investigated as a method of improving outcomes among patients with locally advanced head and neck squamous cell carcinoma. Previous studies have consisted of heterogeneous populations with both p16-positive and p16-negative disease and varying extent of nodal disease burden. We evaluated the role of ICT in p16-positive oropharyngeal squamous cell carcinoma (OPSCC) at high-risk of distant failure. MATERIALS AND METHODS: A retrospective review was conducted of 88 consecutive patients with p16-positive OPSCC with low-neck and/or N3 lymphadenopathy. Among these patients, 44 received ICT followed by CCRT, and 44 received CCRT alone with concurrent agents including Cisplatin, Carboplatin, and Cetuximab. Disease control and survival outcomes were reported after adjusting for age, T stage, N stage, and smoking status. RESULTS: Median follow-up for surviving patients was 47 (range: 13-115) months. Patients who received CCRT alone were older than those who received ICT (61 years vs. 56 years; p = 0.02); the groups were otherwise similarly balanced. 3-year distant metastasis: 38% vs. 18% (adjusted hazard ratio (HR) = 0.32 [0.13-0.82]; p = 0.02). 3-year progression-free survival: 49% vs. 74% (adjusted HR = 0.46 [0.22-0.93]; p = 0.03). 3-year overall survival: 67% vs. 83% (adjusted HR = 0.48 [0.21-1.12]; p = 0.09). CONCLUSION: Among patients with p16-positive OPSCC with low-neck and/or N3 lymphadenopathy, ICT followed by CCRT may reduce the risk for distant failure over CCRT alone and lead to improved progression-free survival. Future trials should concentrate on patients at the highest risk of distant metastasis in order to appropriately assess the benefit of ICT.


Asunto(s)
Carcinoma de Células Escamosas/terapia , Quimioradioterapia , Genes p16 , Quimioterapia de Inducción , Neoplasias Orofaríngeas/terapia , Adulto , Anciano , Anciano de 80 o más Años , Carcinoma de Células Escamosas/genética , Femenino , Humanos , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Neoplasias Orofaríngeas/genética , Resultado del Tratamiento
2.
Am J Clin Oncol ; 37(3): 255-60, 2014 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-23241504

RESUMEN

OBJECTIVES: To compare the outcomes of skull base meningiomas treated with stereotactic radiosurgery (SRS), hypofractionated stereotactic radiotherapy (hFSRT), and fractionated stereotactic radiotherapy (FSRT). METHODS: A total of 220 basal meningiomas in 213 patients were treated using SRS (N=55), hFSRT (N=22), and FSRT (N=143). The median age was 59 years (28 to 84 y). Prior surgery was performed in 74 cases; 39 patients received adjuvant radiotherapy after incomplete resection and 35 patients received salvage radiotherapy after tumor progression. In 146 cases, radiation was the primary therapy. Ten patients had World Health Organization II or III meningiomas. RESULTS: The median follow-up was 32 months (7 to 97 mo). Median tumor volume was 2.8 cm (0.10 to 16.94 cm), 4.8 cm (0.88 to 20.38 cm), and 11.1 cm (0.43 to 214.00 cm) and the median dose was 1250 cGy in 1 fraction to the 80% isodose line (IDL), 2500 cGy in 5 fractions to the 90% IDL, and 5040 cGy in 28 fractions to the 90% IDL for the SRS, hFSRT, and FSRT groups, respectively. Radiographic control was achieved in 91%, 94%, and 95% (P=0.25), whereas clinical response was seen in 89%, 100%, and 91% (P=0.16) in the SRS, hFSRT, and FSRT groups, respectively. CONCLUSIONS: There is no significant difference in the radiographic and clinical response in patients with skull base meningioma treated with SRS, hFSRT, or FSRT and thus gives the clinician the impetus to tailor treatment techniques to the location and size of the tumor at presentation.


Asunto(s)
Fraccionamiento de la Dosis de Radiación , Meningioma/radioterapia , Radiocirugia/métodos , Neoplasias de la Base del Cráneo/radioterapia , Adulto , Anciano , Anciano de 80 o más Años , Progresión de la Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Masculino , Meningioma/patología , Meningioma/cirugía , Persona de Mediana Edad , Neoplasia Residual/radioterapia , Radioterapia Adyuvante/métodos , Terapia Recuperativa , Neoplasias de la Base del Cráneo/patología , Neoplasias de la Base del Cráneo/cirugía , Resultado del Tratamiento , Carga Tumoral
4.
J Colloid Interface Sci ; 255(1): 119-28, 2002 Nov 01.
Artículo en Inglés | MEDLINE | ID: mdl-12702376

RESUMEN

Heterocoagulation of large and small oppositely charged colloid particles, accompanied by spreading of small beads over the surface of large spheres, offers a promising alternative to synthesis of core-shell particles via interfacial polymerization. In this paper, conditions required for complete spreading of the shell-forming polymer over the surface of the core-forming material (CFM) are predicted in terms of a critical distance, x(cr), between the small particles on the surface of the CFM. The theoretical value of x(cr) is tested in experiments conducted for polypyrrole/polyacrylic and silica-titanyl sulfate/polyacrylic heterocoagulate units.

SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...